You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Sale Disclosure
Coloma Jason V · SEC Form 4 · Filed Aug 5, 2026
Sale
Calculated transaction value
$809.54K
Coloma Jason V Chief Executive Officer
MAZE
Maze Therapeutics
MAZE
Transaction date
Aug 3, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 2 days later
MAZE daily price context
Close on/before transaction
$27.33
Aug 3, 2026
First close after public filing
$28.53
Aug 6, 2026
30-day return after filing
-8.13%
Through Sep 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 30,304 shares @ $26.71
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001676170-26-000016
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$922.32K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE Current | Sale | Aug 3, 2026 | $809.54K |
| Maze Therapeutics, Inc. MAZE | Sale | Aug 3, 2026 | $4.17K |
| Maze Therapeutics, Inc. MAZE | Sale | Aug 3, 2026 | $43.44K |
| Maze Therapeutics, Inc. MAZE | Sale | Aug 3, 2026 | $65.16K |